Skip to main content
  • Home
  • About Journal
    • Aim and Scope
    • Editorial Policy
    • Peer Review Process
    • Bibliographic Listings
  • Editorial Board
  • For Authors
    • Information for Authors
    • Article Submission and Charges
    • Submit Article
    • Downloads
  • Contact Us
Pharmacognosy Journal
An Open Access, Peer Reviewed Journal in the field of
Pharmacognosy

Search form

Pharmacognosy Journal
  • Articles In Press
  • Current Issue
  • Archives
  • RSS Feeds
  • Submit Article
Home / Articles in images

Articles in images

PhcogJ_IMG
Map of Nias Island
Number of cells expressing MUC5AC during gastric ulcer repair
Leishmanicidal activity of A) Ehw-4d1, B) Ehw-5b2, C) Ehw-6c4 and D) Ehw-6c3, over the growth of axenic amastigotes of Leishmania mexicana.
PhcogJ_IMG
Average achene length of Cannabis sativa var. indica strains.
PhcogJ_IMG
PhcogJ_IMG
PhcogJ_IMG
Viability result test of RAW264.7 cells on pure ethanol extracts by MTT assay.
Effect of punicalagin (PNG) treatment on serum creatinine of gentamicin (GEN)-challenged rats.
PhcogJ_IMG
Gallic acid reference standard curve.
Flowchart of the study.
PhcogJ_IMG
The absorbance of Dayak onion bulb ethanol extract and its fractions
Setup for different water extracts and control group (each column represents a group, and each cage contains two rats).
Prevalence of bacterial infections in hospitalised and non-hospitalised patients.
Scatter Plot Analysis of the Correlation between IL-6 and Hepcidin Levels in TDT Patients with Alloimmunization/Autoimmunization.
Prediction transmembrane of SERT using TMHMM.
3D Structure of CAMKK2 A. mutation T85S and B. mutation A363S.
PhcogJ_IMG
PhcogJ_IMG
PhcogJ_IMG
The representative images of IL-1β, IL-6, TNF-α, and IL-10 cytokines expression in subventricular zone.
Photomicrographs of sections of representative testes of male rats showing the effects of subacute administration
A representative depiction of (A) CD4+ and (B) CD8+ proportions using flow cytometry
Expression NGF immunohistochemistry 24 hours post treatment in the group without treatment ( weak intensity : +) (A) treatment group  without Kaempferia galanga L extract (medium intensity: ++) (B) treatment group and received 600 mg/kgbb Kaempferia galanga L extract (medium  intensity: ++) (C) group treatment and received 1200 mg/kgbb Kaempferia galanga L extract (strong intensity: +++) (D) (40 times magnification).
Histopathological description of wistar rat (Rattus norvegicus)  osteoblast cells in the group: (a) negative control, (b) positive control, and  (c) ramania leaf extract gel with a concentration of 15% on day 14 after  tooth extraction.
 Article selection flow diagram. Source: Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting  systematic reviews.
Summary of Interview Results for Policy Recommendations COVID-19 Vaccination Program in South Sulawesi Province
Flow diagram of study selection.
Flow diagram of study selection.
Research results related to the use of rainwater using rain harvesting methods
Three months after interpolated pedicle flap surgery.
Dengue Virus RNA promoter structure
Output target of efficient hospitals
The main keys in the innovation culture metric in hospital.
Boxplot of Caspase-3 expression of RGC based on Mann Whitney  analysis.
Graph Degree of Damage to Lung Tissue
Time course of (A) bodyweight increase, (B) knee joint diameter, (C) ipsilateral knee-bend score in control group rats, before and after injection  of MIA and CFA into the left knee joint.
Sample analysis experiment scheme
Sample characteristics and TNM study sample
Characteristics of research subjects
 MTT cell proliferation assay. (a) Cytotoxic effect of EEP from T.  laeviceps on MCF-7 breast cancer cells. Shown here is the dose-dependent  response with an IC50 value of 79.45 µg/ml; p < 0.0001 compared to control  group, one-way ANOVA
3D model of the molecular binding site on cysteinyl leukotriene receptor 1 (CysLTR1) for antiallergic agents. A) Leukotriene D4 (LTD4) (brown)  and montelukast (blue) share the same site. B) Binding of 6-dehydrogingerdione (purple). C) Binding of gingerenone-A (purple). D) Binding of gingerol  (purple). E) Binding of paradol (purple). (purple). F) Binding of quercetin (purple). G) Binding of zingerone (purple). H) Binding of zingiberol (purple). I)  Binding of α-farnesene (purple). J) Binding of zingiberene
Paeonia anomala L grows in Mongolia

Pages

  • « first
  • ‹ previous
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • next ›
  • last »

Submit your Next Article

  • Online submission
  • Highly indexed and abstracted
  • 10 years of successful publishing
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review

Submit your next article to Phcog J

and be a part of many successful authors.
Create free account  / Login

About

Pharmacognosy Journal (Phcog J.) covers different topics in natural product drug discovery, and also publishes manuscripts that describe pharmacognostic investigations, evaluation reports, methods, techniques and applications of all forms of medicinal plant research
Distinctions:  The most widely read, cited, and known Pharmacognosy journal and website is well browsed with all the articles published. More than 50,000 readers in nearly every country in the world each month
ISSN : 0975-3575 ; Frequency : Rapid at a time publication (6 issues/year)
Indexed and Abstracted in : SCOPUS, Scimago Journal Ranking, Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Index Copernicus, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Pharmacognosy Journal is an open access journal, which allows authors to fund their article to be open access from publication. 

 

Submit your Next Article

  • Online submission
  • Highly indexed and abstracted
  • 10 years of successful publishing
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review

Submit your next article to Phcog J

and be a part of many successful authors.
Create free account  / Login

Copyright © 2020 Pharmacogn J. All rights reserved.

Pharmacognosy Journal and its contents are licensed under a Creative Commons Attribution-Non Commercial-No Derivs 4.0 License. Permissions beyond the scope of this license may be available with  editor@phcogj.com

  • Home
  • Advertise with us
  • Privacy Statement